Evaluating Nine-Year Sustainability After Implementing Evidence-Based Practices to Prevent Urinary Tract Infections and Overfilling of the Bladder in Patients with Hip Fracture
Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Mar 22, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well certain practices can help prevent urinary tract infections (UTIs) and bladder overfilling in older patients who have undergone surgery for hip fractures. It looks at a specific program that was introduced to help manage urinary catheters, which are tubes used to drain urine from the bladder. The program includes training for nurses and a certification for catheter care. Researchers want to see if these practices are still effective nine years after they started, especially after they had to pause during the pandemic. They will focus on patients aged 65 and older who had hip surgery and were treated in specialized wards.
To be eligible for this trial, participants must be 65 years or older, have had hip fracture surgery at the study site, and received care in the ortho-geriatric wards. Participants will be monitored for any changes in UTIs, bladder overfilling, and how well the urinary catheter care is documented. This research is important as it could help improve care not just for hip fracture patients, but also for other surgical patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Hip fracture surgery at the study site, age 65 years and older and cared for in the ortho-geriatric wards.
- Exclusion Criteria:
- • -No catheterisation during hospital stay
About Sahlgrenska University Hospital
Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mölndal, Västra Götaland, Sweden
Patients applied
Trial Officials
Annette Erichsen, Associate Professor
Principal Investigator
Gothenburg University, Sahlgrenska University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported